1. 260 Low incidence of both new-onset and flares of uveitis in secukinumab-treated patients with ankylosing spondylitis: clinical trial and post-marketing safety analysis. (12th April 2019) Authors: Marzo-Ortega, Helena; Deodhar, Atul; Miceli-Richard, Corinne; Baraliakos, Xenofon; Gladman, Dafna D; Martin, Ruvie; Safi, Jorge; Porter, Brian; Shete, Abhijit Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period. (12th April 2019) Authors: McInnes, Iain B; Deodhar, Atul; Gladman, Dafna D; Ren, Mengyuan; Spindeldreher, Sebastian; Pricop, Luminita; Porter, Brian; Safi, Jorge; Shete, Abhijit; Bruin, Gerard Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies. Issue 5 (30th April 2020) Authors: Deodhar, Atul A.; Miceli‐Richard, Corine; Baraliakos, Xenofon; Marzo‐Ortega, Helena; Gladman, Dafna D.; Blanco, Ricardo; Das Gupta, Ayan; Martin, Ruvie; Safi, Jorge; Porter, Brian; Shete, Abhijit; Rosenbaum, James T. Journal: ACR open rheumatology Issue: Volume 2:Issue 5(2020) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inhibition of IL‐17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections. Issue 8 (25th August 2017) Authors: Kammüller, Michael; Tsai, Tsen‐Fang; Griffiths, Christopher EM; Kapoor, Nidhi; Kolattukudy, Pappachan E; Brees, Dominique; Chibout, Salah‐Dine; Safi, Jorge; Fox, Todd Journal: Clinical & translational immunology Issue: Volume 6:Issue 8 (2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P191 Secukinumab demonstrates a consistent safety profile in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis over long term: updated pooled safety analyses. (26th April 2021) Authors: McInnes, Iain B; Baraliakos, Xenofon; Deodhar, Atul; Gottlieb, Alice B; Lebwohl, Mark; Schreiber, Stefan; Marfo, Kwaku; Bao, Weibin; Richards, Hanno B; Pricop, Luminita; Shete, Abhijit; Safi, Jorge; Mease, Philip J Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗